Please assess the completion status of the following clinical trial:

Trial Title: Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. Symptomatic Hypertrophic Cardiomyopathy patients~2. Abnormal Peak VO2~3. No significant LVOT obstruction at rest (gradient \< 30mmHg)~4. Sinus rhythm~Exclusion Criteria:~1. Abnormal LFT.~2. Concomitant use of amiodarone~3. Pre-existing evidence of peripheral neuropathy.~4. Women of childbearing potential.~5. Patients with ICD's will be excluded from the MR part of the study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).